Selective GRB2 SH2 inhibitors as anti-Ras therapy
Authors:
- 8 October 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 83 (2) , 235-241
Abstract
Given the key role of Ras in the mitogenic signaling by receptor tyrosine kinases, several targets upstream of Ras may prove to be excellent targets for drugs in the treatment of cancer caused by oncogenic tyrosine kinases. CGP78850 is a potent competitor of Grb2 SH2‐phosphopeptide interactions. This inhibitor has been obtained by rational drug design and is specific toward the Grb2 SH2 vs. other SH2 domains and the PTB domain of SHC in vitro. Accordingly, CGP78850 blocks epidermal growth factor receptor (EGFR)‐Grb2 and Shc‐Grb2 interactions in living cells. It also inhibits the growth of cells transformed by receptor tyrosine kinases, which transmit a proliferative signal through Grb2 to Ras, but not cells transformed by oncogenic Raf or cells that contain activating Ras mutations. Moreover, our results demonstrate that, in cells overexpressing receptor tyrosine kinases, such as the EGFR, Grb2 SH2 inhibitors induce expression of the cell cycle inhibitors p21Waf1/Cip1/CAP1 and p27Kip1 and reverse transformation. Int. J. Cancer 83:235–241, 1999.Keywords
This publication has 13 references indexed in Scilit:
- Structure-Based Design and Synthesis of High Affinity Tripeptide Ligands of the Grb2-SH2 DomainJournal of Medicinal Chemistry, 1998
- Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding modeNature Structural & Molecular Biology, 1996
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Ras regulatory interactions: Novel targets for anti‐cancer intervention?BioEssays, 1994
- Regulation of ras signal transduction in normal and transformed cellsCellular Signalling, 1994
- Specificity in recognition of phosphopeptides by src-homology 2 domainsJournal of Cell Science, 1994
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- Prevalence of aberrant expression of the epidermal growth factor receptor in human cancersBritish Medical Bulletin, 1991
- TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreasCell, 1990
- Synthesis and Evaluation of Some Novel Phosphoramidate Derivatives of 3′-Azido-3′-Deoxythymidine (AZT) as Anti-HIV CompoundsAntiviral Chemistry and Chemotherapy, 1990